White label – Pompe disease - ClinicalTrials.eu

Study on the Use of Metformin in Addition to Standard Treatment for Patients with Glioblastoma

Recruiting

2 1 1 1
Investigated Diseases:
- Glioblastoma
Investigated Drugs:
- Metformin Embonate
Study on Cabozantinib and Nivolumab for Older Patients with Kidney Cancer

Recruiting

3 1 1 1
Investigated Drugs:
- Cabozantinib
- Nivolumab
Study on Reducing Acute Kidney Injury After Heart Surgery Using Angiotensin II or Noradrenaline for Patients with Low Blood Pressure

Recruiting

3 1 1 1
Investigated Drugs:
- ANGIOTENSIN II
- Noradrenaline Tartrate
Study Comparing Metformin and Tolvaptan for Adults with Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Recruiting

3 1 1 1
Investigated Diseases:
- Congenital cystic kidney disease
Investigated Drugs:
- Metformin
- Tolvaptan
Study on the Effects of Metolazone, Acetazolamide, and a Drug Combination for Patients with Chronic Heart Failure

Recruiting

3 1 1 1
Investigated Drugs:
- Metolazone
- Acetazolamide
Study on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer

Recruiting

3 1 1 1
Investigated Diseases:
- Colorectal cancer metastatic
- Colorectal cancer
Investigated Drugs:
- Capecitabine
- Fluorouracil
Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

Recruiting

2 1 1
Investigated Diseases:
- Neoplasm
- Non-small cell lung cancer metastatic
Investigated Drugs:
- VERT-002
Study of Vosoritide for Children with Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome Not Responding to Growth Hormone

Recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Vosoritide
Study on the Effectiveness and Safety of Alpelisib for Patients with Dent 2 Disease

Recruiting

2 1 1 1
Investigated Diseases:
- Dent’s disease
Investigated Drugs:
- Alpelisib
Study on the Effectiveness and Safety of BAY 2927088 for Patients with Advanced Solid Tumors with HER2 Mutations

Recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies